Cheche Group Inc. financials

Cheche Group Inc. reports to SEC EDGAR in CNY (it files a 20-F/40-F as a foreign private issuer), so every monetary figure below is in CNY as filed, not US dollars.
CCG CIK 0001965473

Source: EDGAR filings · Built 2026-06-19T00:37:48Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2023FY 2023FY 2023
Free Cash Flow -40.63M -115.80M -27.50M -160.10M -189.22M
EBITDA -18.79M -64.44M -165.68M -113.56M -153.59M
Working Capital 250.37M 302.54M 278.72M 256.81M
Net Debt -48.68M -82.30M -204.04M -101.04M -359.38M
Gross Margin 5.33% 4.57% 4.25% 5.31% 4.66%
Operating Margin -0.69% -1.92% -5.08% -4.33% -8.97%
Net Margin -0.59% -1.76% -4.83% -3.40% -8.44%
Return on Equity (ROE) -5.01% -17.21% -42.20% 7.22% 14.57%
Return on Assets (ROA) -1.21% -4.75% -17.85% -12.78%
Current Ratio 1.23× 1.34× 1.56× 1.75×
Debt-to-Equity 0.27× 0.10× 0.10× -0.01× -0.00×
Effective Tax Rate 2.23% 0.47% 0.23% 0.57% 0.36%
Cash Conversion Ratio 2.28× 1.86× 0.17× 1.75× 1.28×
Accruals Ratio 0.02× 0.04× -0.15× 0.10×
SBC % of Revenue 0.81% 0.98% 3.33% 0.60% 1.07%
CapEx Coverage -540.67× -68.63× -49.09× -128.11× -115.44×
Free Cash Flow Per Share ¥-0.49 ¥-1.48 ¥-0.61 ¥-5.04 ¥-5.59

Income Statement

Concept FY 2025FY 2024FY 2023FY 2023FY 2023FY 2023
Revenue from Contract with Customer, Excluding Assessed Tax 3.01B 3.47B 3.30B 2.68B
Revenues 3.01B 3.47B 3.30B 2.68B 1.74B
Cost of Revenue 2.85B 3.31B 3.16B 2.54B 1.65B
Gross Profit 160.36M 158.76M 140.22M 142.31M 80.81M
Research and Development Expense 37.24M 37.95M 57.17M 49.95M 46.78M
Operating Expenses 181.25M 225.31M 308.01M 2.80B 236.52M
Operating Income (Loss) -20.89M -66.54M -167.78M -115.95M -155.71M
Income Tax Expense (Benefit) -406.00K -291.00K -363.00K -521.00K -522.00K
Net Income (Loss) Attributable to Parent -17.79M -61.24M -159.59M -91.02M -146.46M
Earnings Per Share, Basic ¥-0.22 ¥-0.78 ¥-20.30 ¥-8.79 ¥-1.33
Weighted Average Number of Shares Outstanding, Basic 82.58M 78.04M 45.42M 31.78M 33.83M
Earnings Per Share, Diluted ¥-0.22 ¥-0.78 ¥-20.30 ¥-8.79 ¥-1.33
Weighted Average Number of Shares Outstanding, Diluted 82.58M 78.04M 45.42M 31.78M 33.83M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2023FY 2023FY 2023
Cash and Cash Equivalents, at Carrying Value 144.51M 117.47M 243.39M 114.94M 362.38M
Assets, Current 1.36B 1.18B 780.25M 600.85M
Assets 1.47B 1.29B 893.98M 712.50M
Liabilities, Current 1.11B 878.27M 501.53M 344.03M
Long-term Debt, Excluding Current Maturities 9.80M
Liabilities 1.12B 932.17M 515.79M 414.16M
Stockholders' Equity Attributable to Parent 355.17M 355.75M 378.18M -1.26B -1.01B -804.57M
Common Stock, Shares, Outstanding 80.32M 83.02M 75.44M 31.78M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2023FY 2023FY 2023
Net Cash Provided by (Used in) Operating Activities -40.55M -114.14M -26.95M -158.86M -187.59M
Payments to Acquire Property, Plant, and Equipment 75.00K 1.66M 549.00K 1.24M 1.63M
Net Cash Provided by (Used in) Investing Activities 35.40M -15.60M 12.82M 27.69M -65.33M
Net Cash Provided by (Used in) Financing Activities 55.40M 1.95M 140.34M -159.04M 583.67M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CCG CIK 0001965473), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ARMP

ARMATA PHARMACEUTICALS, INC.

GWTI

GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES

RARE

ULTRAGENYX PHARMACEUTICAL INC.